Interleukin 6 G-174 C polymorphism and breast cancer risk

European Journal of Epidemiology

Volumn 21, Issue 5, 2006, Pages 373-376

  Gonzalez Zuloeta Ladd A M ^a   Arias Vasquez A ^a   Witteman, J ^a   Uitterlinden, A G ^a   Coebergh, J W ^a   Hofman, A ^a   Stricker, B H Ch ^a   Van Duijn, C M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Breast cancer; IL 6; Polymorphism

Indexed keywords

INTERLEUKIN 6;

ADULT; ALLELE; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER RISK; CAUCASIAN; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; POSTMENOPAUSE; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE;

AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CYSTEINE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLYCINE; HUMANS; INTERLEUKIN-6; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 33745906543     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-006-9005-1     Document Type: Article

References (20)

1. Smith KC, Bateman AC, Fussell HM, Howell WM. Cytokine gene polymorphisms and breast cancer susceptibility and prognosis. Eur J Immunogenet 2004; 31: 167-173.
2. Hefler LA, Grimm C, Ackermann S, et al. An interleukin-6 gene promoter polymorphism influences the biological phenotype of ovarian cancer. Cancer Res 2003; 63: 3066-3068.
3. Berger FG. The interleukin-6 gene: A susceptibility factor that may contribute to racial and ethnic disparities in breast cancer mortality. Breast Cancer Res Treat 2004; 88: 281-285.
4. Iacopetta B, Grieu F, Joseph D. The -174 G/C gene polymorphism in interleukin-6 is associated with an aggressive breast cancer phenotype. Br J Cancer 2004; 90: 419-422.
5. DeMichele A, Martin AM, Mick R, et al. Interleukin-6 -174G- > C polymorphism is associated with improved outcome in high-risk breast cancer. Cancer Res 2003; 63: 8051-8056.
6. Yamamoto T, Matsuda T, Junicho A, Kishi H, Saatcioglu F, Muraguchi A. Cross-talk between signal transducer and activator of transcription 3 and estrogen receptor signaling. FEBS Lett 2000; 486: 143-148.
7. Belluco C, Olivieri F, Bonafe M, et al. -174 G > C polymorphism of interleukin 6 gene promoter affects interleukin 6 serum level in patients with colorectal cancer. Clin Cancer Res 2003; 9: 2173-2176.
8. Bachelot T, Ray-Coquard I, Menetrier-Caux C, Rastkha M, Duc A, Blay JY. Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients. Br J Cancer 2003; 88: 1721-1726.
9. Zhang GJ, Adachi I. Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma. Anticancer Res 1999; 19: 1427-1432.
10. Basolo F, Conaldi PG, Fiore L, Calvo S, Toniolo A. Normal breast epithelial cells produce interleukins 6 and 8 together with tumor-necrosis factor: Defective IL6 expression in mammary carcinoma. Int J Cancer 1993; 55: 926-930.
11. Fontanini G, Campani D, Roncella M, et al. Expression of interleukin 6 (IL-6) correlates with oestrogen receptor in human breast carcinoma. Br J Cancer 1999; 80: 579-584.
12. Karczewska A, Nawrocki S, Breborowicz D, Filas V, Mackiewicz A. Expression of interleukin-6, interleukin-6 receptor, and glycoprotein 130 correlates with good prognoses for patients with breast carcinoma. Cancer 2000; 88: 2061-2071.
13. Humphries SE, Luong LA, Ogg MS, Hawe E, Miller GJ. The interleukin-6 -174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. Eur Heart J 2001; 22: 2243-2252.
14. Vickers MA, Green FR, Terry C, et al. Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein. Cardiovasc Res 2002; 53: 1029-1034.
15. Hefler LA, Grimm C, Lantzsch T, et al. Interleukin-1 and interleukin-6 gene polymorphisms and the risk of breast cancer in caucasian women. Clin Cancer Res 2005; 11: 5718-5721.
16. Hofman A, Grobbee DE, de Jong PT, van den Ouweland FA. Determinants of disease and disability in the elderly: The Rotterdam Elderly Study. Eur J Epidemiol 1991; 7: 403-422.
17. Garrow JS. Quetelet index as indicator of obesity. Lancet 1986; 1: 1219.
18. Bijlsma F, van der Esch EP. [PALGA, of labor pains of the Pathological Anatomical District Automatized Archives] PALGA, of de barensweeen van een Pathologisch Anatomisch Landelijk Geautomatiseerd Archief. Ned Tijdschr Geneeskd 1972; 116: 902-903.
19. Raymond M, Genepop RF. Population genetics software for exact tests and ecumenism. J Heredity 1986; 86: 248-249(version 1.2).
20. Mitrunen K, Hirvonen A. Molecular epidemiology of sporadic breast cancer. The role of polymorphic genes involved in oestrogen biosynthesis and metabolism. Mutat Res 2003; 544: 9-41.